Stay updated with breaking news from New ophthalmic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lorrainosaurus Uppsala University Pliosaur Plesiosaur Oldest-Known Mega-Predatory Marine Reptile Revealed By Fossils Of 170-Year-Old Organism abplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from abplive.com Daily Mail and Mail on Sunday newspapers.
Ocuphire Pharma Initiates LYNX-1 Phase 3 Study Investigating Nyxol in Night Vision Disturbances January 05, 2021 07:00 ET | Source: Ocuphire Pharma Ocuphire Pharma Nyxol is in Late Stage Clinical Development for A New Ophthalmic Indication Top Line Data from LYNX-1 Expected 3Q2021 FARMINGTON HILLS, Mich., Jan. 05, 2021 (GLOBE NEWSWIRE) Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, announced the initiation of patient recruitment and screening in late December for its LYNX-1 Phase 3 registration study evaluating the safety and efficacy of Nyxol ® in night vision disturbances (NVD) at multiple sites in the US. ....